| Literature DB >> 31429156 |
Xin-Shang Wang1,2, Jiao Yue1,2, Li-Ning Hu1,2, Zhen Tian1,2,3, Kun Zhang1,2, Le Yang1,2, Hui-Nan Zhang1,2, Yan-Yan Guo1,2, Bin Feng4, Hai-Yan Liu4, Yu-Mei Wu1,2, Ming-Gao Zhao1,2, Shui-Bing Liu1,2.
Abstract
Ischemic stroke leads to neuronal damage induced by excitotoxicity, inflammation, and oxidative stress. Astrocytes play diverse roles in stroke and ischemia-induced inflammation, and autophagy is critical for maintaining astrocytic functions. Our previous studies showed that the activation of G protein-coupled receptor 30 (GPR30), an estrogen membrane receptor, protected neurons from excitotoxicity. However, the role of astrocytic GPR30 in maintaining autophagy and neuroprotection remained unclear. In this study, we found that the neuroprotection induced by G1 (GPR30 agonist) in wild-type mice after a middle cerebral artery occlusion was completely blocked in GPR30 conventional knockout (KO) mice but partially attenuated in astrocytic or neuronal GPR30 KO mice. In cultured primary astrocytes, glutamate exposure induced astrocyte proliferation and decreased astrocyte autophagy by activating mammalian target of rapamycin (mTOR) and c-Jun N-terminal kinase (JNK) and inhibiting p38 mitogen-activated protein kinase (MAPK) pathway. G1 treatment restored autophagy to its basal level by regulating the p38 pathway but not the mTOR and JNK signaling pathways. Our findings revealed a key role of GPR30 in neuroprotection via the regulation of astrocyte autophagy and support astrocytic GPR30 as a potential drug target against ischemic brain damage.Entities:
Keywords: GPR30; astrocyte; autophagy; neuroprotection; p38 MAPK
Mesh:
Substances:
Year: 2019 PMID: 31429156 DOI: 10.1002/glia.23697
Source DB: PubMed Journal: Glia ISSN: 0894-1491 Impact factor: 7.452